Photodermatol Photoimmunol Photomed:使用高分辨率表面超声研究格雷夫斯病的周围淋巴对UVA-1光疗的初步反应

2018-12-18 MedSci MedSci原创

意大利锡耶纳大学医学院外科和神经科学系的Tognetti L等人近日在Photodermatol Photoimmunol Photomed杂志是发表了一篇文章,他们使用高分辨率表面超声研究格雷夫斯病的周围淋巴对UVA-1光疗的初步反应。

意大利锡耶纳大学医学院外科和神经科学系的Tognetti L等人近日在Photodermatol Photoimmunol Photomed杂志是发表了一篇文章,他们使用高分辨率表面超声研究格雷夫斯病的周围淋巴对UVA-1光疗的初步反应。

格雷夫斯眼眶病(GO)和胫前混合水肿(PTM)是一种自身免疫疾病的症状,它们具有相同的病因和组织病理学特征。这是一种慢性病,目前的治疗方案令人沮丧。

目前的治疗包括局部和全身性皮质类固醇药物治疗,这被当做一线治疗。而环孢菌素、手术和眼眶放疗等措施适用于严重的GO,治疗结果有较大的差异,且只是起到临时缓解的作用。特别是在眼球突出和眼睑收缩的病例中,由于视神经和眼外肌的压迫,引起眼睛活动、复视受损的角膜病和畏光等疾病,上述治疗措施通常有微小的疗效。因此,作者采用高分辨率表面超声方法,对格雷夫斯病的周围淋巴进行细致研究。

原文出处:

Tognetti, L., et al., Preliminary experience of the use of high-resolution skin ultrasound for the evaluation of extrathyroideal manifestations of Graves' disease and response to UVA-1 phototherapy. Photodermatol Photoimmunol Photomed, 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1936167, encodeId=731b193616e4e, content=<a href='/topic/show?id=bf8a10222582' target=_blank style='color:#2F92EE;'>#高分辨率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102225, encryptionId=bf8a10222582, topicName=高分辨率)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIW7uIr5ebYvJohUq0dkkVV05uF9jPpeyCrlcx904mUdMI9UKqpO3bt4GkgYBNdv485qT2NsVE27w/132, createdBy=023c2500122, createdName=ms8543593053280928, createdTime=Sun Jan 06 08:01:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788732, encodeId=18c21e887321c, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sun Nov 24 09:01:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997607, encodeId=9060199e607fd, content=<a href='/topic/show?id=e06810222253' target=_blank style='color:#2F92EE;'>#高分辨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102222, encryptionId=e06810222253, topicName=高分辨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 13 06:01:00 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796667, encodeId=e44d1e96667a4, content=<a href='/topic/show?id=d1b918219c6' target=_blank style='color:#2F92EE;'>#UVA-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18219, encryptionId=d1b918219c6, topicName=UVA-1)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Tue Jan 01 10:01:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747899, encodeId=4d231e47899c3, content=<a href='/topic/show?id=77d62883411' target=_blank style='color:#2F92EE;'>#光疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28834, encryptionId=77d62883411, topicName=光疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb1d35982112, createdName=俅侠, createdTime=Thu Oct 03 10:01:00 CST 2019, time=2019-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609385, encodeId=5e541609385b4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Dec 20 13:01:00 CST 2018, time=2018-12-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1936167, encodeId=731b193616e4e, content=<a href='/topic/show?id=bf8a10222582' target=_blank style='color:#2F92EE;'>#高分辨率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102225, encryptionId=bf8a10222582, topicName=高分辨率)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIW7uIr5ebYvJohUq0dkkVV05uF9jPpeyCrlcx904mUdMI9UKqpO3bt4GkgYBNdv485qT2NsVE27w/132, createdBy=023c2500122, createdName=ms8543593053280928, createdTime=Sun Jan 06 08:01:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788732, encodeId=18c21e887321c, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sun Nov 24 09:01:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997607, encodeId=9060199e607fd, content=<a href='/topic/show?id=e06810222253' target=_blank style='color:#2F92EE;'>#高分辨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102222, encryptionId=e06810222253, topicName=高分辨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 13 06:01:00 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796667, encodeId=e44d1e96667a4, content=<a href='/topic/show?id=d1b918219c6' target=_blank style='color:#2F92EE;'>#UVA-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18219, encryptionId=d1b918219c6, topicName=UVA-1)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Tue Jan 01 10:01:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747899, encodeId=4d231e47899c3, content=<a href='/topic/show?id=77d62883411' target=_blank style='color:#2F92EE;'>#光疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28834, encryptionId=77d62883411, topicName=光疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb1d35982112, createdName=俅侠, createdTime=Thu Oct 03 10:01:00 CST 2019, time=2019-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609385, encodeId=5e541609385b4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Dec 20 13:01:00 CST 2018, time=2018-12-20, status=1, ipAttribution=)]
    2019-11-24 liuxiaona
  3. [GetPortalCommentsPageByObjectIdResponse(id=1936167, encodeId=731b193616e4e, content=<a href='/topic/show?id=bf8a10222582' target=_blank style='color:#2F92EE;'>#高分辨率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102225, encryptionId=bf8a10222582, topicName=高分辨率)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIW7uIr5ebYvJohUq0dkkVV05uF9jPpeyCrlcx904mUdMI9UKqpO3bt4GkgYBNdv485qT2NsVE27w/132, createdBy=023c2500122, createdName=ms8543593053280928, createdTime=Sun Jan 06 08:01:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788732, encodeId=18c21e887321c, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sun Nov 24 09:01:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997607, encodeId=9060199e607fd, content=<a href='/topic/show?id=e06810222253' target=_blank style='color:#2F92EE;'>#高分辨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102222, encryptionId=e06810222253, topicName=高分辨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 13 06:01:00 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796667, encodeId=e44d1e96667a4, content=<a href='/topic/show?id=d1b918219c6' target=_blank style='color:#2F92EE;'>#UVA-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18219, encryptionId=d1b918219c6, topicName=UVA-1)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Tue Jan 01 10:01:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747899, encodeId=4d231e47899c3, content=<a href='/topic/show?id=77d62883411' target=_blank style='color:#2F92EE;'>#光疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28834, encryptionId=77d62883411, topicName=光疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb1d35982112, createdName=俅侠, createdTime=Thu Oct 03 10:01:00 CST 2019, time=2019-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609385, encodeId=5e541609385b4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Dec 20 13:01:00 CST 2018, time=2018-12-20, status=1, ipAttribution=)]
    2019-03-13 lsndxfj
  4. [GetPortalCommentsPageByObjectIdResponse(id=1936167, encodeId=731b193616e4e, content=<a href='/topic/show?id=bf8a10222582' target=_blank style='color:#2F92EE;'>#高分辨率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102225, encryptionId=bf8a10222582, topicName=高分辨率)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIW7uIr5ebYvJohUq0dkkVV05uF9jPpeyCrlcx904mUdMI9UKqpO3bt4GkgYBNdv485qT2NsVE27w/132, createdBy=023c2500122, createdName=ms8543593053280928, createdTime=Sun Jan 06 08:01:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788732, encodeId=18c21e887321c, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sun Nov 24 09:01:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997607, encodeId=9060199e607fd, content=<a href='/topic/show?id=e06810222253' target=_blank style='color:#2F92EE;'>#高分辨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102222, encryptionId=e06810222253, topicName=高分辨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 13 06:01:00 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796667, encodeId=e44d1e96667a4, content=<a href='/topic/show?id=d1b918219c6' target=_blank style='color:#2F92EE;'>#UVA-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18219, encryptionId=d1b918219c6, topicName=UVA-1)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Tue Jan 01 10:01:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747899, encodeId=4d231e47899c3, content=<a href='/topic/show?id=77d62883411' target=_blank style='color:#2F92EE;'>#光疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28834, encryptionId=77d62883411, topicName=光疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb1d35982112, createdName=俅侠, createdTime=Thu Oct 03 10:01:00 CST 2019, time=2019-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609385, encodeId=5e541609385b4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Dec 20 13:01:00 CST 2018, time=2018-12-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1936167, encodeId=731b193616e4e, content=<a href='/topic/show?id=bf8a10222582' target=_blank style='color:#2F92EE;'>#高分辨率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102225, encryptionId=bf8a10222582, topicName=高分辨率)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIW7uIr5ebYvJohUq0dkkVV05uF9jPpeyCrlcx904mUdMI9UKqpO3bt4GkgYBNdv485qT2NsVE27w/132, createdBy=023c2500122, createdName=ms8543593053280928, createdTime=Sun Jan 06 08:01:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788732, encodeId=18c21e887321c, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sun Nov 24 09:01:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997607, encodeId=9060199e607fd, content=<a href='/topic/show?id=e06810222253' target=_blank style='color:#2F92EE;'>#高分辨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102222, encryptionId=e06810222253, topicName=高分辨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 13 06:01:00 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796667, encodeId=e44d1e96667a4, content=<a href='/topic/show?id=d1b918219c6' target=_blank style='color:#2F92EE;'>#UVA-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18219, encryptionId=d1b918219c6, topicName=UVA-1)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Tue Jan 01 10:01:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747899, encodeId=4d231e47899c3, content=<a href='/topic/show?id=77d62883411' target=_blank style='color:#2F92EE;'>#光疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28834, encryptionId=77d62883411, topicName=光疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb1d35982112, createdName=俅侠, createdTime=Thu Oct 03 10:01:00 CST 2019, time=2019-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609385, encodeId=5e541609385b4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Dec 20 13:01:00 CST 2018, time=2018-12-20, status=1, ipAttribution=)]
    2019-10-03 俅侠
  6. [GetPortalCommentsPageByObjectIdResponse(id=1936167, encodeId=731b193616e4e, content=<a href='/topic/show?id=bf8a10222582' target=_blank style='color:#2F92EE;'>#高分辨率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102225, encryptionId=bf8a10222582, topicName=高分辨率)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIW7uIr5ebYvJohUq0dkkVV05uF9jPpeyCrlcx904mUdMI9UKqpO3bt4GkgYBNdv485qT2NsVE27w/132, createdBy=023c2500122, createdName=ms8543593053280928, createdTime=Sun Jan 06 08:01:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788732, encodeId=18c21e887321c, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sun Nov 24 09:01:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997607, encodeId=9060199e607fd, content=<a href='/topic/show?id=e06810222253' target=_blank style='color:#2F92EE;'>#高分辨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102222, encryptionId=e06810222253, topicName=高分辨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Mar 13 06:01:00 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796667, encodeId=e44d1e96667a4, content=<a href='/topic/show?id=d1b918219c6' target=_blank style='color:#2F92EE;'>#UVA-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18219, encryptionId=d1b918219c6, topicName=UVA-1)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Tue Jan 01 10:01:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1747899, encodeId=4d231e47899c3, content=<a href='/topic/show?id=77d62883411' target=_blank style='color:#2F92EE;'>#光疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28834, encryptionId=77d62883411, topicName=光疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb1d35982112, createdName=俅侠, createdTime=Thu Oct 03 10:01:00 CST 2019, time=2019-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609385, encodeId=5e541609385b4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Dec 20 13:01:00 CST 2018, time=2018-12-20, status=1, ipAttribution=)]
    2018-12-20 hb2008ye

相关资讯

Nat Commun:骆清铭成功绘制高分辨率全脑图谱

大脑连接组的可视化。来源:nature.com编者按:人的大脑大约有1000亿个神经元,它们如何连接以及错误的连接产生何种问题,一直是人类认知的黑洞。最近,《自然·通讯》杂志发表了华中科技大学骆清铭研究团队的一种称为全脑定位系统的全自动显微成像方法,这项技术有望帮助基础神经科学和临床研究者们最终绘制一个完整脑的神经连接地图,被中外科学家视为”世界一流的工作“。欧美日在数年前纷纷启动了自己的脑计

新内镜技术可避免对所有息肉进行病理检查

圣迭戈(EGMN)——加州退伍军人医学中心的Tonya Kaltenbach博士在美国消化疾病周(DDW)上报告,高分辨率、双焦点结肠镜的应用使得内镜医生可以在内镜下对小息肉做出明显更准确、更可信的诊断,从而向“不必对结肠镜下切除的每一枚息肉都常规做病理检查”的目标迈出了重要一步。   Roy Soetikno博士、Kaltenbach博士及其同事设计了这项名为退伍军人结直肠病变解释

nature biomedical engineering:用于肿瘤检测和图像引导的高分辨率纳米手术探针

近日权威杂志nature biomedical engineering在线发表了一篇研究文章,研究人员通过设计一种具有晶体管响应的纳米探针,由于癌组织中的巨大的遗传和组织学差异,以高分辨率检测广泛的恶性肿瘤很有挑战性。文章中报道的具有晶体管响应的纳米探针放大了肿瘤的荧光信号,产生了一个空间分辨率小于1mm的信号。研究人员通过在肿瘤大鼠上进行实时肿瘤 - 酸中毒指导检测和隐匿性结节手术,显着延长了小